Looking back to 2 days ago, Cempra Inc (NASD: CEMP) priced a 4,166,667 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company, ...

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors’ money because they are ...

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CEMP’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher ...

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking ...

Cempra Inc (NASDAQ:CEMP), a pharmaceuticals company based in United States, saw significant share price volatility over the past couple of months on the NasdaqGS, rising to the highs of $3.85 and ...

Shares of Cempra, Inc.CEMP plunged 57.3% after the company announced that it received a Complete Response Letter (CRL) from the FDA relating to the company's new drug applications (NDAs) for oral and ...

) as a pre-market mover with heavy volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cempra as such a stock due to the following factors: CEMP has an average dollar ...

) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Cempra as such a stock due to the following factors: ...